TLR8 Gene - Toll Like Receptor 8
Key innate immune sensor of single-stranded RNA viruses and regulator of antiviral responses
Gene Information Card
| Symbol | TLR8 |
|---|---|
| Full Name | Toll Like Receptor 8 |
| Gene Type | protein-coding |
| Chromosomal Location | Xp22.2 |
| NCBI Gene ID | 51311 ncbi.nlm.nih.gov/gene/51311 |
| Ensembl ID | ENSG00000101916 |
| UniProt ID | Q9NR97 |
| OMIM ID | 300166 |
| HGNC ID | 11832 |
| Aliases | CD288, IMD98 |
Description
TLR8 (Toll Like Receptor 8) is a member of the Toll-like receptor (TLR) family, which plays a fundamental role in pathogen recognition and activation of innate immunity. TLR8 is predominantly expressed in myeloid cells and recognizes single-stranded RNA (ssRNA) from viruses and endogenous RNA degradation products. Upon ligand binding, TLR8 recruits MYD88 and triggers NF-κB and IRF signaling pathways, leading to pro-inflammatory cytokine production. TLR8 is encoded on the X chromosome and is closely related to TLR7. Mutations in TLR8 are associated with X-linked immunodeficiency and autoinflammatory conditions.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| X-linked immunodeficiency with recurrent infections | Loss-of-function TLR8 variants impair ssRNA sensing, reducing type I interferon and cytokine responses | ClinVar, OMIM |
| Systemic lupus erythematosus (SLE) | Gain-of-function TLR8 variants enhance IFN-α production, promoting autoantibody formation | NCBI, OMIM |
| Rheumatoid arthritis | TLR8 overexpression in synovial macrophages drives TNF-α and IL-6 production | NCBI, UniProt |
| Viral susceptibility (e.g., influenza, SARS-CoV-2) | Defective TLR8 signaling reduces antiviral cytokine responses | ClinVar, COSMIC |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lung | 12.5 | Medium |
| Spleen | 8.3 | Medium |
| Blood (whole) | 6.1 | Low |
| Bone marrow | 5.4 | Low |
| Liver | 2.1 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| Monocytes (THP-1) | 15.2 | High expression |
| Macrophages (differentiated) | 18.7 | High expression |
| Dendritic cells (immature) | 9.8 | Medium expression |
| B lymphocytes (Raji) | 1.3 | Low expression |
| T lymphocytes (Jurkat) | 0.5 | Not detected |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1Val) | Missense | <0.01% | Loss of function; associated with X-linked immunodeficiency |
| c.1048C>T (p.Arg350*) | Nonsense | <0.01% | Loss of function; premature stop codon |
| c.1634G>A (p.Arg545Gln) | Missense | 0.02% | Gain of function; increased NF-κB activation |
| c.2159T>C (p.Ile720Thr) | Missense | 0.01% | Gain of function; linked to SLE |
Mutation functional classification
Loss of Function (LOF)
Loss-of-function mutations (e.g., p.Met1Val, p.Arg350*) impair TLR8 trafficking or ligand binding, leading to reduced cytokine production and increased susceptibility to viral infections.
Gain of Function (GOF)
Gain-of-function mutations (e.g., p.Arg545Gln, p.Ile720Thr) enhance TLR8 signaling, resulting in excessive pro-inflammatory cytokine release and autoimmunity.
Dominant Negative (DN)
No dominant-negative mutations have been reported for TLR8.
View complete mutation data:
Gene Ontology (GO)
| • GO:0002224 - toll-like receptor signaling pathway | • GO:0035666 - TRIF-dependent toll-like receptor signaling pathway |
| • GO:0002376 - immune system process | • GO:0045087 - innate immune response |
| • GO:0003725 - double-stranded RNA binding | • GO:0003727 - single-stranded RNA binding |
| • GO:0004872 - receptor activity | • GO:0016021 - integral component of membrane |
Pathways
• Toll-like receptor signaling pathway (KEGG: hsa04620)
• MyD88-dependent cascade (Reactome: R-HSA-166058)
• NF-κB activation (Reactome: R-HSA-975110)
• IRF7-mediated type I interferon signaling (Reactome: R-HSA-933541)
Protein Summary
TLR8 is a 1,041-amino acid transmembrane protein with an extracellular leucine-rich repeat (LRR) domain responsible for ligand recognition, a transmembrane domain, and a cytoplasmic Toll/IL-1 receptor (TIR) domain that initiates downstream signaling. The protein is localized to endosomal membranes and is activated by uridine-rich ssRNA and certain synthetic agonists (e.g., imidazoquinolines). TLR8 exists as a preformed dimer; ligand binding induces conformational changes that recruit MYD88. Post-translational modifications include N-glycosylation essential for proper folding and trafficking. UniProt ID: Q9NR97.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TLR8 Knockout HEK293 Cell Line | EDJ-KQ2816 | Human | 51311 | Details Get a Quote |
| TLR8 Knockout HeLa Cell Line | EDJ-KQ56281 | Human | 51311 | Details Get a Quote |
| TLR8 Knockout A-549 Cell Line | EDJ-KQ64769 | Human | 51311 | Details Get a Quote |
| TLR8 Knockout HCT 116 Cell Line | EDJ-KQ73217 | Human | 51311 | Details Get a Quote |
| TLR7 and TLR8 Knockout THP-1 Cell Line | EDC07593 | Human | 51284 and 51311 | Details Get a Quote |
| TLR7 & TLR8 Overexpression THP-1(TLR7 -/-&TLR8-/-) cell Stable Cell Line | EDC01653 | Human | 51284 & 51311 | Details Get a Quote |
| TLR8 Overexpression THP-1(TLR7 -/-&TLR8-/-) cell Stable Cell Line | EDC01652 | Human | 51311 | Details Get a Quote |
Displaying Records 1 To 7 Of 7 Records